CompletedNCT04912609

Trehalose Administration in Subjects With Spastic Paraplegia 11 (3AL-SPG11)

Studying Autosomal recessive spastic paraplegia type 11

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: IRCCS Fondazione Stella Maris
Principal Investigator: Filippo M Santorelli, MD PhD
Filippo Santorelli-Lab Med Molecolare
Enrollment: 13 enrolled
Eligibility: 10 years · All sexes
Timeline: 2021 – 2022

Study locations (1)

IRCCS Fondazione Stella Maris, Pisa, PI, Italy

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04912609 on ClinicalTrials.gov

← Back to all trials